Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

596 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of novel aminothiazole-comprising 5-LO inhibitors.
M Kretschmer SB, Woltersdorf S, Rödl CB, Vogt D, Häfner AK, Steinhilber D, Stark H, Hofmann B. M Kretschmer SB, et al. Among authors: hofmann b. Future Med Chem. 2016;8(2):149-64. doi: 10.4155/fmc.15.174. Epub 2016 Jan 29. Future Med Chem. 2016. PMID: 26824797
Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor.
Wisniewska JM, Rödl CB, Kahnt AS, Buscató El, Ulrich S, Tanrikulu Y, Achenbach J, Rörsch F, Grösch S, Schneider G, Cinatl J Jr, Proschak E, Steinhilber D, Hofmann B. Wisniewska JM, et al. Among authors: hofmann b. Biochem Pharmacol. 2012 Jan 15;83(2):228-40. doi: 10.1016/j.bcp.2011.10.012. Epub 2011 Oct 18. Biochem Pharmacol. 2012. PMID: 22027220
Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazoles.
Kretschmer SB, Woltersdorf S, Vogt D, Lillich FF, Rühl M, Karas M, Maucher IV, Roos J, Häfner AK, Kaiser A, Wurglics M, Schubert-Zsilavecz M, Angioni C, Geisslinger G, Stark H, Steinhilber D, Hofmann B. Kretschmer SB, et al. Among authors: hofmann b. Biochem Pharmacol. 2017 Jan 1;123:52-62. doi: 10.1016/j.bcp.2016.09.021. Epub 2016 Sep 23. Biochem Pharmacol. 2017. PMID: 27671344
Exploring the chemical space of multitarget ligands using aligned self-organizing maps.
Achenbach J, Klingler FM, Blöcher R, Moser D, Häfner AK, Rödl CB, Kretschmer S, Krüger B, Löhr F, Stark H, Hofmann B, Steinhilber D, Proschak E. Achenbach J, et al. Among authors: hofmann b. ACS Med Chem Lett. 2013 Oct 23;4(12):1169-72. doi: 10.1021/ml4002562. eCollection 2013 Dec 12. ACS Med Chem Lett. 2013. PMID: 24900624 Free PMC article.
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418.
Maucher IV, Rühl M, Kretschmer SB, Hofmann B, Kühn B, Fettel J, Vogel A, Flügel KT, Manolikakes G, Hellmuth N, Häfner AK, Golghalyani V, Ball AK, Piesche M, Matrone C, Geisslinger G, Parnham MJ, Karas M, Steinhilber D, Roos J, Maier TJ. Maucher IV, et al. Among authors: hofmann b. Biochem Pharmacol. 2017 Feb 1;125:55-74. doi: 10.1016/j.bcp.2016.11.004. Epub 2016 Nov 4. Biochem Pharmacol. 2017. PMID: 27823964
596 results